OCRF has awarded nearly $6 million in grants for ovarian cancer research this year. After receiving over 170 applications – the highest number in its history, for the second year in a row – OCRF and its prestigious Scientific Advisory Committee endeavored first and foremost to fund the best science. The Committee evaluated each proposal through intensive peer review, and selected a sound portfolio of 2013 grants that represent the present and future of ovarian cancer research.

“We received a very healthy number of solid applications this year, and the depth, breadth and quality of our awards only continues to increase,” says Jeff Boyd, Ph.D., OCRF’s Scientific Advisory Committee Chair and Board Member, and Senior Vice President, Molecular Medicine at Fox Chase Cancer Center. “These scientists are at the top of their game at the national level. The caliber of our grantees and their projects is outstanding – on par with those funded by any other major agency in the country. This speaks to the power and importance of OCRF in the ovarian cancer research community.”

OCRF’s 2013 grants, which range from $75,000 to $900,000, were awarded to 16 scientists. To date, OCRF has invested over $50 million in ovarian cancer research, awarding 195 grants to scientists at 63 leading medical centers in the United States.

Read the official press release here.